Monthly Updates: Everything You Need to Know About Pharma News
The season of golden pumpkins and soothing rains is almost over, leaving us with some important news and changes in the world of healthcare and pharmaceuticals. Let’s unwind briefly and discuss what happened in the past month and what lies ahead.
In our newsletter, we have gathered all the latest updates you need to know about. Check them out right now or save the article for later:
How the US election will affect the healthcare sector
Elections always have the power to affect multiple industries all at once, and healthcare is no exception. The cost of medicine, the Affordable Care Act, and even pharmaceutical sales can change depending on future policies and laws. In this guide, you can learn more about how the victory of Donald Trump might impact the healthcare sector, as well as what could have happened if Kamala Harris had won:
Viseveners came together for the Customer Experience Awards ceremony in October
This October, we acknowledged the importance of customer experience during the Customer Experience Awards ceremony. Every interaction, decision, and idea shape the experience we offer to our customers, who are at the heart of all our operations. We are grateful for everyone who makes miracles happen here at Viseven, and we hope to continue innovating in the years to come!
New PAGB research highlights the importance of self-care for easy-to-treat conditions
The Self-Care Census 2024 report revealed the latest trends in self-care in around 4,000 adults from the UK. According to the collected data, 22% of respondents do not find self-care the first solution to easy-to-treat conditions and ailments. The research uncovers the truth about awareness of the benefits of self-care and the behavioral differences in self-treatment practices across different age groups:
23andMe ends drug development and slashes staff
23andMe, renowned for its genetic testing services that people across the world widely use, decided to restructure the business, end its drug development operations, and lay off 40% of its workforce, amounting to about 200 workers. These actions are a response to continuous losses in earnings, as the company has been struggling to increase profits since going public in 2021. Follow the link to find out more about the changes 23andMe is going through right now:
Recommended by LinkedIn
Zendesk 2025 CX Trends Report: Human-Centric AI Drives Loyalty
Zendesk’s 2025 Customer Experience (CX) Trends Report has arrived, and it reveals how much customer expectations have changed over the past year. The research discovers more about how consumers feel about human-like AI agents, AI-driven interactions, personalized services, and other trends. Thanks to the report that accumulated insights from over 10,000 customers and business leaders, companies can fine-tune their customer experience strategy and better incorporate artificial intelligence into their operations:
EMA’s strategy for speeding up drug approvals in the EU
The European Medicines Agency had a few difficult years due to Brexit and the COVID-19 pandemic. However, EMA persevered, and after moving from one city to another and dealing with disrupted operations, the agency has come up with a strategy to speed up drug approvals in the European Union. EMA aims to improve communication with applicants, reduce delays, and create a new, more efficient approval process. Read on for more information about the agency’s challenges and solutions:
Artificial Intelligence to Reshape Creative and Measurement and the Publisher-Advertiser Relationship
Many will agree that AI is a disruptive force capable of changing many industries in previously unimaginable ways. 2024 Marketing AI Institute research demonstrates that 99% of survey participants already use AI both in their personal lives and at work. How far will the AI revolution go, and what can companies do about it? This article provides all of the insights:
That’s all for now; however, there is much more exciting news and many events coming up in the next few months, so stay tuned!